Manjari Palla

Sep 13, 2023 | outsourcedpharma.com | Kriti Khandelwal |Manjari Palla |Ramesh Mullangi |John Baumann |Louis Garguilo

Is the growing demand for small molecule outsourcing impeding your ability to find a reliable partner with capacity? Don’t miss Outsourced Pharma Capacity Update — a virtual event focused entirely on the available capacity and related service area capabilities, volumes, locations, and facilities of CDMOs. This multiday event is conveniently grouped by molecule type and will feature small molecule partner presentations on October 4th. Registration is free.

Sep 1, 2023 | pharmaceuticalonline.com | Kriti Khandelwal |Manjari Palla |Jeff Phillips |Nathan Dormer

Macro Impacts From The Micro-UniverseThe popular PDA Pharmaceutical Microbiology Conference will once again bring together speakers from industry, regulatory agencies, and academia to address relevant challenges and opportunities in the field.

Aug 8, 2023 | outsourcedpharma.com | Kriti Khandelwal |Manjari Palla |Louis Garguilo

Guest Column | August 8, 2023 By Kriti Khandelwal and Manjari Palla, DataM Intelligence After two decades of trial and error in antibodydrug conjugates (ADC) development, the field is poised to deliver a plethora of targeted drugs to treat a wide range of tumor types. These are an emerging class of highly potent pharmaceutical drugs that are a combination of immunotherapy and chemotherapy.